ISRCTN10125751Terminated未知
Experience of rucaparib as maintenance treatment following platinum-based chemotherapy in relapsed ovarian cancer - a UK real-world study
HS Greater Glasgow and Clyde0 sites34 target enrollmentStarted: June 30, 2021Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Terminated
- Sponsor
- Enrollment
- 34
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Sex
- Female
Inclusion Criteria
- •1. Women where a decision has been made to start rucaparib as part of standard care for maintenance treatment recurrent ovarian cancer following to platinum based chemotherapy and they have not yet started treatment
- •2. Written informed consent
- •3. Ability and willingness to complete questionnaires in English
- •4. Meet institutional criteria for treatment in standard practice
Exclusion Criteria
- •1. Prior treatment with a poly ADP ribose polymerase (PARP) inhibitor
- •2. Current treatment with another maintenance therapy for ovarian cancer
- •3. Participation in another trial of an investigational medicinal product (IMP) (participation in another observational or sample collection trial may be possible if both Sponsors agree and the burden on the patient is acceptable)
Investigators
Similar Trials
Active, not recruiting
Phase 1
Study of Rucaparib in Patients with Locally Advanced or Metastatic Urothelial Carcinomaocally Advanced Unresectable or Metastatic Urothelial CarcinomaMedDRA version: 20.0Level: LLTClassification code 10064467Term: Urothelial carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10044412Term: Transitional cell carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2017-004166-10-GBClovis Oncology, Inc.200
Active, not recruiting
Phase 1
Study of Rucaparib in Patients with Locally Advanced or Metastatic Urothelial Carcinomaocally Advanced Unresectable or Metastatic Urothelial CarcinomaMedDRA version: 21.0Level: PTClassification code 10044412Term: Transitional cell carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: LLTClassification code 10064467Term: Urothelial carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2017-004166-10-ITCLOVIS ONCOLOGY, INC97
Active, not recruiting
Phase 1
Study of Rucaparib in Patients with Locally Advanced or Metastatic Urothelial CarcinomaEUCTR2017-004166-10-DEClovis Oncology, Inc.97
Active, not recruiting
Phase 1
Study of Rucaparib in Patients with Locally Advanced or Metastatic Urothelial Carcinomaocally Advanced or Metastatic Urothelial CarcinomaMedDRA version: 20.0Level: LLTClassification code 10064467Term: Urothelial carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10044412Term: Transitional cell carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2017-004166-10-FRClovis Oncology, Inc.97
Active, not recruiting
Phase 1
Study of Rucaparib in Patients with Locally Advanced or Metastatic Urothelial CarcinomaEUCTR2017-004166-10-ESClovis Oncology, Inc.200